Why the study?
CRT may be pro-arrhythmic in patients with non-LBBB, prompting investigation into whether assessing risk factors for ventricular tachyarrhythmias can stratify these patients for CRT implantation.
Does CRT-D compared to ICD-only therapy affect the risk of ventricular tachyarrhythmias in non-LBBB patients, and how do specific risk factors modify this effect?
RCT (n=412)
randomized
Does CRT-D compared to ICD-only therapy affect the risk of ventricular tachyarrhythmias in non-LBBB patients, and how do specific risk factors modify this effect?
Answers are grounded in this paper and cite their sources.
A combined assessment of four risk factors (BUN >25mg/dl, EF <20%, prior nonsustained VT, and female gender) can identify non-LBBB patients who may experience pro-arrhythmic effects from CRT-D, aiding in patient selection.
INTRODUCTION: Cardiac resynchronization therapy (CRT) may be pro-arrhythmic in patients with non-left bundle branch block (non-LBBB). We hypothesized that combined assessment of risk factors (RF) for ventricular tachyarrhythmias (VTAs) can be used to stratify non-LBBB patients for CRT implantation. METHODS: The study comprised 412 non-LBBB patients from MADIT-CRT randomized to CRT-D (n = 215) versus ICD only (n = 197). Best-subset regression analysis was performed to identify RF associated with increased VTA risk in CRT-D patients without LBBB. The primary end point was first occurrence of sustained VTA during follow-up. Secondary end points included VTA/death and appropriate shock. RESULTS: Four RFs were associated with increased VTA risk: blood urea nitrogen >25mg/dl, ejection fraction <20%, prior nonsustained VT, and female gender. Among CRT-D patients, 114 (53%) had no RF, while 101 (47%) had ≥1 RF. The 4-year cumulative probability of VTA was higher among those with ≥1 RF compared with those without RF (40% vs. 14%, p < .001). Multivariate analysis showed that in patients without RF, treatment with CRT-D was associated with a 61% reduction in VTA compared with ICD-only therapy (p = .002), whereas among patients with ≥1 RF, treatment with CRT-D was associated with a corresponding 73% (p = .025) risk increase. Consistent results were observed when the secondary end points of VTA/death and appropriate ICD shocks were assessed. CONCLUSION: Combined assessment of factors associated with increased risk for VTA can be used for improved selection of non-LBBB patients for CRT-D.
No takes yet. Share an insight, caveat, or question.
Younis et al. (2021) conducted an RCT in non-left bundle branch block (non-LBBB) (n=412). CRT-D vs. ICD only was evaluated on first occurrence of sustained VTA during follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: